MolDX: Prometheus® IBD sgi Diagnostic® Policy

The Prometheus IBD sgi Diagnostic test is non-covered and should not be billed for use in differentiating IBD vs non-IBD or Crohn's disease vs ulcerative colitis. The test comprises 17 reported biomarkers (nine serologic markers, four SNPs, five inflammatory markers) and a proprietary algorithmic IBD score, but neither the panel nor algorithmic interpretation is covered under this policy.

"The Prometheus IBD sgi Diagnostic test (including its 17-biomarker panel and proprietary Smart Diagnostic Algorithm) is non-covered for use to differentiate inflammatory bowel disease (IBD) vs non-..."

Sign up to see full coverage criteria, indications, and limitations.